Key result
Fluid overload and high angiopoietin-2 linked to ~114% higher dialysis risk in CKD stages 3-5.
Why the study?
Does the combination of fluid overload and high circulating Angpt2 increase the risk of adverse renal outcomes in patients with CKD stages 3-5?
Cohort (n=290)
No
Does the combination of fluid overload and high circulating Angpt2 increase the risk of adverse renal outcomes in patients with CKD stages 3-5?
Fluid overload and high circulating Angiopoietin-2 have a synergistic effect on increasing the risk of adverse renal outcomes in patients with CKD stages 3-5.
Answers are grounded in this paper and cite their sources.
Combined fluid overload and high Angpt2 linked to higher dialysis risk in CKD; hypothesis-generating for synergy, needs prospective validation.
BACKGROUND: Fluid overload is not only the characteristic but also an important complication in chronic kidney disease (CKD) patients. Angiopoietin-2 (Angpt2) disturbs endothelium and vessel permeability, which may induce fluid overload. The aim of this study is to examine the interaction between fluid status and Angpt2 in adverse renal outcomes of CKD. METHODS: This cohort study enrolled 290 patients with CKD stages 3-5 from January 2011 to December 2011 and followed up until December 2015. Fluid status was presented as overhydration (OH) value measured by body composition monitor, while OH>1.1L was defined as fluid overload. Renal outcomes were defined as commencing dialysis and rapid renal function decline (the slope of estimated glomerular filtration rate < -5 ml/min/1.73 m2/y). RESULTS: During a mean follow-up of 38.6±18.3 months, 125 (43.1%) patients progressed to commencing dialysis and 99(34.7%) patients presented rapid renal function decline. All patients were stratified by OH of 1.1L and the median of circulating Angpt2. These patients with both OH>1.1L and high circulating Angpt2 were more likely to reach commencing dialysis compared to other groups. The risks for commencing dialysis and rapid renal function decline were significantly higher in patients with OH>1.1L and high circulating Angpt2 level compared to those with OH≦1.1L and low circulating Angpt2 (2.14, 1.21-3.78, P = 0.009; 4.96, 1.45-16.97, P = 0.01). There was a significant interaction between OH level and circulating Angpt2 in entering dialysis (P-interaction = 0.02). CONCLUSIONS: Fluid overload and Angpt2 might have a synergistic effect on adverse renal outcomes in CKD patients.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2017) conducted a cohort in Chronic kidney disease (CKD) stages 3-5 (n=290). Fluid overload (OH > 1.1L) and high circulating Angiopoietin-2 vs. Normal fluid status (OH ≤ 1.1L) and low circulating Angiopoietin-2 was evaluated on Commencing dialysis (HR 2.14, 95% CI 1.21-3.78, p=0.009). The combination of fluid overload and high circulating angiopoietin-2 levels significantly increased the risk of commencing dialysis (HR 2.14) in patients with chronic kidney disease stages 3-5.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: